FDA openFDA Drug Enforcement (recalls)·· 7 天前精选AI 评分92
FDA召回EAGLE PHARMA OUTSOURCING生产的去甲肾上腺素盐酸盐注射液
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
AI 导读
FDA数据显示，EAGLE PHARMA OUTSOURCING生产的去甲肾上腺素盐酸盐注射液（PHENYLephrine HCL Infusion，100 mg/250 mL，0.4 mg/mL）因无菌保证缺失（Lack of Assurance of Sterility）被召回。该药品为处方药，单剂量容器，NDC编号为69852-100-25。
推荐理由
FDA官方召回数据，涉及无菌保证缺陷，对药品安全具有直接参考价值。
来源：FDA openFDA Drug Enforcement (recalls) · api.fda.gov